Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 134.00
Bid: 131.00
Ask: 137.00
Change: 0.00 (0.00%)
Spread: 6.00 (4.58%)
Open: 132.00
High: 134.00
Low: 132.00
Prev. Close: 134.00
NBS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Nationwide for Business

3 Apr 2020 07:00

RNS Number : 6644I
Nationwide Building Society
03 April 2020
 

Friday 3rd April 2020 0700hrs 

 

Inside Information Notice

 

This announcement is released by Nationwide Building Society and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR). For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Alison Robb, Deputy Chief Financial Officer of Nationwide Building Society.

 

Nationwide Building Society halts plans to enter the business banking market as it focuses on its existing members' financial priorities 

  

  

Nationwide Building Society ('Nationwide') has today announced that it is stopping plans to enter the UK business banking market as it prioritises supporting its members through the immediate and longer-term financial implications of COVID-19.  

  

The impact of COVID-19, including assumption changes to short and long-term interest rates, has meant that the option of entering the business banking market is no longer commercially viable. As a consequence of its decision, Nationwide will cease activity directly related to its proposed market entry, it will return the £50 million grant funding it was awarded from the Banking Competition Remedies' Capability and Innovation Fund, as announced in May 2019, and won't participate in the Incentivised Switching Scheme. 

  

The financial implications of the cancellation will be disclosed within Nationwide's preliminary full year results for 2019/2020. At this stage, Nationwide estimates the costs of cancellation will be in the region of £70 million in 2020 but running cost and investment savings will make this a net neutral cost over the next 24 months. All employees will be redeployed to other roles within Nationwide.

  

Today's announcement does not impact Nationwide's business savings accounts which will continue to operate as normal.

  

Nationwide Building Society CEO, Joe Garner, said: "Our priority as a building society must always be our existing members and employees. COVID-19 has changed the medium-term interest rate landscape, meaning the business case for entering the market is no longer viable. Therefore, our absolute focus will be on supporting our members and our employees through the immediate difficult time and future financial implications of the virus." 

  

-Ends- 

  

  

Media information contact:  

Eden Black, eden.black@nationwide.co.uk, 07793 596317 

Michelle Slade, michelle.slade@nationwide.co.uk, 07725 680135 

  

Notes: 

  

In May 2019, Nationwide was awarded a £50 million grant from Banking Competition Remedies' Capability and Innovation Fund in order to 'develop a new business current account or ancillary product propositions for SMEs in the UK'. Nationwide will return this grant award and any other sums that may be due to BCR. 

  

In March 2019, Nationwide took a £15 million investment in 10x Future Technologies as part of its plans to build to a new cloud-native platform for its business current account and related products. Nationwide plans to continue to work with 10x Future Technologies in the application of the platform for the Society's existing and future product ranges. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUPUQACUPUPUP
Date   Source Headline
25th Apr 20248:40 amRNSPre Stabilisation Notice - Nationwide dual covered
23rd Apr 202411:33 amRNSForm 8.3 - Virgin Money UK PLC
23rd Apr 202411:28 amRNSForm 8.3 - Virgin Money UK PLC
22nd Apr 20247:00 amRNSPublication of Scheme Document
17th Apr 20243:05 pmRNSForm 8.3 - Virgin Money UK plc
12th Apr 20243:53 pmRNSPublication of Final Terms
11th Apr 20243:58 pmRNSForm 8.5 (EPT/NON-RI) - Virgin Money UK Plc 25 Mar
5th Apr 20243:44 pmRNSPublication of Suppl.Prospcts
28th Mar 20241:50 pmRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc 26 Mar
28th Mar 20241:47 pmRNSForm 8.5 (EPT/RI) - Virgin Money UK PLC 25 Mar
25th Mar 202412:43 pmRNSForm 8.5 (EPT/RI) - Virgin Money Uk Plc
25th Mar 202412:40 pmRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc
25th Mar 202412:39 pmRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc
21st Mar 202411:55 amRNSForm 8 - Nationwide Building Society - Replacement
21st Mar 20247:00 amRNSRecommended cash offer for Virgin Money UK PLC
19th Mar 202411:37 amRNSForm 8.5 (EPT/RI) - Virgin Money Uk Plc 14 MAR
19th Mar 202411:36 amRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc
19th Mar 202411:31 amRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc 15 Mar
19th Mar 202411:30 amRNSForm 8.5 (EPT/RI) - Virgin Money Uk Plc 14 Mar
19th Mar 202411:29 amRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc 13 MAR
19th Mar 202411:28 amRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc 12 MAR
19th Mar 202411:26 amRNSForm 8.5 (EPT/RI) - Virgin Money Uk Plc 11 MAR
19th Mar 202411:24 amRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc 8 MAR
15th Mar 20243:14 pmRNSForm 8 (OPD) (Nationwide Building Society))
8th Mar 20243:54 pmRNSForm 8.5 (EPT/RI) - Virgin Money
7th Mar 20247:00 amRNSJoint Statement Re Potential Cash Acquisition
27th Dec 20237:00 amRNSPost Stabilisation Notice - Nationwide
8th Dec 20233:53 pmRNSPublication of Supplementary Prospectus
27th Nov 20234:34 pmRNSPublication of Final Terms
17th Nov 20232:15 pmRNSPublication of Suppl.Prospcts
17th Nov 20237:00 amRNSHalf-year Report
10th Nov 20232:45 pmRNSPublication of Final Terms
9th Nov 20232:45 pmRNSPublication of Final Terms
7th Nov 20237:00 amRNSPublication of Suppl.Prospcts
30th Oct 20235:36 pmRNSPublication of Final Terms
30th Oct 20237:00 amRNSPublication of Final Terms
24th Oct 20233:03 pmRNSPublication of Final Terms
20th Oct 20235:11 pmRNSPublication of a Prospectus
17th Oct 202310:44 amRNSPublication of Final Terms
2nd Oct 202310:25 amRNSRedemption of Notes
27th Sep 20233:50 pmRNSPublication of Final Terms
15th Sep 202311:02 amRNSPublication of a Prospectus
4th Sep 202310:49 amRNSPublication of Final Terms
4th Sep 202310:49 amRNSPublication of Final Terms
17th Aug 20235:49 pmRNSPublication of Final Terms
16th Aug 20234:43 pmRNSPublication of Final Terms
14th Aug 20234:19 pmRNSPublication of Final Terms
10th Aug 20233:23 pmRNSPublication of Final Terms
8th Aug 20234:15 pmRNSPublication of Final Terms
28th Jul 202312:24 pmRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.